mitomycin has been researched along with Thymoma in 4 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Thymoma: A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hama-Inaba, H | 1 |
| Wang, B | 1 |
| Mori, M | 1 |
| Matsushima, T | 1 |
| Saitoh, T | 1 |
| Takusagawa, M | 1 |
| Yamada, T | 1 |
| Muto, M | 1 |
| Ohyama, H | 1 |
| Kataoka, T | 1 |
| Ito, M | 1 |
| Budd, RC | 1 |
| Tschopp, J | 1 |
| Nagai, K | 1 |
| Ujiie, T | 1 |
| Ryoyama, K | 1 |
| Ryoyama, C | 1 |
4 other studies available for mitomycin and Thymoma
| Article | Year |
|---|---|
Radio-sensitive murine thymoma cell line 3SB: characterization of its apoptosis-resistant variants induced by repeated X-irradiation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Daunorubicin; Drug Resistance; Genetic Variation; Methyl | 1998 |
Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells.
Topics: Animals; Apoptosis; Camptothecin; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein | 2002 |
Immunogenic potential of tumor cells after treatment with antitumor chemotherapeutic agents.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Cyclophosphamide; Cyto | 1988 |
Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host.
Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Immunity, Cellular; Immunotherapy; In V | 1989 |